GNTA insider transaction filings
Genenta Science S.p.A. — 6 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-05-05. Screen GNTA transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-05 | 4 | Paracchi Pierluigi — Chief Executive Officer, Director, 10% owner | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | PARACCHI GIACOMOANTONIO — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | Mutti Miguel Maria — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | Sharei Armon — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | Galimi Francesco — CMO& Head of Development, Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | SLANSKY RICHARD B — Chief Financial Officer | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=GNTA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →